chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The morning after my vaccine (5/18/2021), I woke up with a mild headache and achiness in my joints. I took ibuprofen to alleviate the pain and my headache came back later that afternoon. I started feeling nauseous in the evening before going to bed.  The following morning (5/19/2021), I woke up with the same headache and was feeling nauseous still. After about an hour, I got out of bed thinking I was going to vomit. I was sitting on the bathroom floor and became lightheaded and my stomach started hurting worse. I got tunnel vision  and passed out. My boyfriend was there and said that I started seizing for about 10 seconds and was cold. He said that I started to urinate and then regained consciousness after about 15 seconds. He called 911. I felt shaky and dizzy for about 15 min after. The ambulance showed up. My blood pressure was low, blood sugar was good, heart rate was good. I was able to walk to the ambulance and they took me to the ER. They gave me anti-nausea medication and fluids via IV. At the hospital, I received a CT scan for my head and another to check for clots in my lungs. Both tests came back negative. I had chills and body aches and was extremely tired.  After about a couple of hours, I started feeling nauseous again and they gave me more anti-nausea medication. They did a urine sample and said I had a UTI, but other than that there was nothing wrong. They referred me to a neurologist to follow up about the seizure. They prescribed an antibiotic for the UTI and anti-nausea medication and I was discharged after about 5 hours.
The following morning after 2nd dose, my head felt foggy for a few hours and I also woke up dizzy.  The dizziness lasted a couple of hours.  I woke up dizzy for the next 3 days following my second dose.  Dizzy symptoms lasted 1-2 hours each morning for 4 days following second dose.
About 1 1/2 hours, post vax, pt started complaining of itching and red blotches on chest, back and arms. Went to school nurse and she stated she had trouble locating her mother. In about an hour, the rash and itching were gone. At 20:00, that night, pt complained of headache and vomited. Mother stated pt has history of migraines with nausea and vomiting. She was given naproxen and she was fine the next day. CDC Immun. hotline recommended that pt get an allergy skin tests for MMR and HEP-B vaccine to determine if allergic to either before proceeding with next HEP-B vaccine.
Secondary transmission; I gave the chicken pox to my partner who has suffered greatly with fever, and rash all over his body; Information has been received regarding a case in litigation for zoster vaccine live (ZOSTAVAX) (MARRS # 1810USA013278) from a factsheet and physician medical record, concerning a male patient who was vaccinated with zoster vaccine live (ZOSTAVAX) on 19-MAY-2015.  The male reported that "I gave the chicken pox to my partner who has suffered greatly with fever, and rash all over his body."  The male partner (of unknown age) was "Put into quarantine for 1.5 weeks."  The male partner was diagnosed on 09-NOV2016.  This was considered to be a secondary transmission. The outcome of the chickenpox, fever and rash was not reported.  The medical record 24-OCT-2016 reported the male was in a mutually monogamous relationship.  All available medical records will be provided upon request. Additional information is not expected.; Sender's Comments:  US-009507513-1810USA013278:
Blisters on bilateral palms of hands, knuckles, elbows, knees and bottom of feet. Blisters range in size of 1-22mm. Does not appear in distress. Is alert and active. Parent denies child with fever, itching or malaise.
sick; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of sickness in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   Family history included ophthalmic herpes zoster (patient's mother got it by her eyes) and shingles (patient's sister had it in back).   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine and Shingles vaccine, the patient experienced sickness (Verbatim: sick). The outcome of the sickness was resolved.   It was unknown if the reporter considered the sickness to be related to Shingles vaccine and Shingles vaccine.     It was unknown if the company considered the sickness to be related to Shingles vaccine and Shingles vaccine.   Additional Information: GSK receipt date: 19-MAR-2023 The case was received from the patient interactive digital media. The patient stated that he/she never gotten it, but he/she know family members and old coworkers that had and they had all told him/her how horrible it was.  The patient's mother got it by her eyes and it caused such bad eye problems and she got surgery and she was much better.  The patient's sister got it early in her life, all over her back.  The patient had a coworker that was out five weeks, during covid.  The reporter asked if she had coronavirus.  She said she was on her stomach for weeks on end, and walked around her house topless because clothes hurt her back so much.  The patient stated that convinced him/her to get both shingles vaccines.  The patient stated that those vaccines both made him/her very sick, but he/she got over it.  The patient hoped that he/she never get shingles. The follow-up could not be possible as no contact details were available.
Fatigue, weakness/lack of energy, malaise, nausea, fever of 99.9, feeling hot and cold alternately, redness and pain at the vaccination site, trouble sleeping, and upper arm pain (even when arm is not being moved or touched).  All symptoms lasted from 4 PM on 2/14/2021 until 10:30 PM on 2/15/2021. Some tiredness noted on morning of 2/16/2021, but seemed to improve by early afternoon. Redness still present at the vaccination site and pain when touching site still noted, but all other symptoms have since resolved. Treatment included taking Butal-Acetaminophen-Caffeine and Naproxen, as well as heating pad to site and exercising arm.
Patient noticed a small shingles like rash on her left cheek on the morning of 11/8. She stated that it itched and burned. We advised her to follow up with her doctor.
Information has been received from a registered nurse concerning a 16 female, with no pertinent medical history, who on 19-DEC-2006 was vaccinated IM with a 0.5 ml dose of Gardasil (lot # 653938/0954F).  There was no concomitant medication.  Subsequently 5 weeks after her second dose the patient developed a right upper arm mass at the injection site.  She was seen by an orthopedic physician who diagnosed the mass as a granuloma.  The orthopedic physician reported that the vaccine was "self contained" in the granuloma.  The patient had a complete blood cell count (results not reported).  Subsequently, the patient recovered.  At the time of the report, the patient has not had the third dose.  Additional information has been requested.
Pt broke out with rash the evening of the same day of her HPV vaccine. It was welt like and itchy. Eyes were puffy. Rash on trunk, arms and legs. Seen 2d later, already resolving. Rx antihistamine, CORTAID CREAM.
VOMITING for two days after shot and ondansetron prescribed, SWOLLEN GLANDS ON LEFT SIDE NECK AND CLAVICAL AREA, NUMBNESS IN HANDS AND FINGERS, RAISED BLOOD PRESSURE, 103F FEVER on DAY AFTER SHOT
Within a few minutes of receiving the vaccine, the patient felt dizzy and fell to the ground without LOC.  Was supine on floor with legs elevated for less than 5 minutes when insisted on getting up.  Immediately experienced dizziness again.  Sat in chair and attempted to drink some water.  He experienced less than 1 second episode of stiffening of arms and vomited the water.  Put head between knees for 15 minutes and then was able to get up with no more dizziness or nausea.
The padded area on my hands between my thumb and pointer finger became swollen; Injection site pain; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207), via an unknown route of administration in right arm on 21Mar2021 at 14:30 (at an age of 63-year-old) as single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported. The patient was allergic to biaxin. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 21Mar2021 at 15:30, the patient experienced swelling in the padded area on the hands between the thumb and pointer finger, injection site pain and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcomes of swelling in the padded area on the hands between the thumb and pointer finger was resolved (for a couple hours) on 21Mar2021, while that of injection site pain was resolved (lasted for 24 hours) on 22Mar2021 and fatigue was resolved on an unknown date of Mar2021.  No follow-up attempts are needed. No further information is expected.
SkinRash sob , rash and pain at injection site. Narrative:  sob started 1/5/2021 7pm and was gone the next morning. No coughing. Couldn't take a deep breath.
Tempt to 102 for 3 days. Cough for 5 days. No treatment.
This spontaneous report was received from a registered nurse refers to an unspecified number of patients of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On an unknown dates, the patients were vaccinated with improperly stored doses of RECOMBIVAX HB which had lot # M010611 with expiry: 02-JUN-2018, lot # M022077 with 10-MAR-2019 and lot # M023718 with expiry: 09-MAY-2018 (dosing details not provided). The vaccines were exposed to a temperature excursion of 9 degree Celsius for 1 hour 24 minutes, with an additional excursion for 10 degree Celsius for 2 hours for lot # M010611 with expiry: 02-JUN-2018 and lot # M022077 with expiry: 10-MAR-2019. No adverse effects reported. No further information provided. This is one of several reports received from the same reporter. Additional information has been requested.
Information has been received from a nurse referring to an unspecified number of unspecified patients of unknown age and gender. On unspecified dates, these patients were vaccinated with an unspecified number of improperly stored doses of VAQTA (lot # L023232 with expiration 25-FEB-2017; lot # L009445 with expiration 01-JUN-2017; lot # was reported as L02375 with expiration 12-JAN-2017; dose, frequency and route were not reported). No adverse effects were reported. This is one of several cases received from the same source. Additional information has been requested.
This spontaneous report as received from a pharmacist refers to a 62 years old female patient. The patient had no pertinent medical history and drug reactions. The patient was vaccinated with ZOSTAVAX (lot number reported as H013017, expiration date 09-OCT-2013) subcutaneously on 11-OCT-2012. No other co-suspects were reported. There were no concomitant medications. On 12-OCT-2012 the patient experienced "a red rash one to one-and-a-half inches in diameter around the injection site which was also warm and had some hardness associated with it". No treatment was given for adverse event. No laboratory diagnostics studies were performed. The outcome of adverse event was reported as not recovered. The patient stopped into the pharmacy for seek medical attention. Additional information is not expected.
I had itching and burning on my right elbow and then the appearance of red bumps (clusters) and I granuloma annular and that it was possible that the vaccine triggered the immune system. My Doctor offered to inject the bumps with asteroids and I opted to use the cream that he prescribed for me which I don't use it often. I still have three clusters; however, the others are no longer visible. He did not need to perform any tests after my examination because he recognized the granuloma annular which disappeared and re-appeared after I took the Moderna vaccine. I did have one other very strange rash that came after 6th or 7th day after the vaccine on the left forearm near my enter wrist formed which was the size of a dollar. It became really red and itchy after I came out of the shower and it went away a month later. Whenever I got up during the episode, the rash would be very red and itchy. I told my doctor about it but he did not see anything (provided him with a picture of the rash). The red bumps are still on my elbow and continue to become itchy and burns.
Pain, swelling, warmth on right leg Narrative: Patient received 1st dose of Moderna Vaccine on 08/04/2021, reported muscle pain the following (2) days then reported pain on her right leg on 08/07/2021. Patient then proceeded to report limping, swelling and warmth on the affected right leg and proceeded to self-medicate with 8--mg of Ibuprofen with no relief. Upon report from patient, COVID vaccination nurses recommended patient to seek further assistnce from nearest Emergency Room on 08/09/2021
After administration, the patient sat down for 10-15min. mark in the waiting area. However: within the next few min. after the shot patient had twerking motions of her hands and feet and said that she's having a blurred vision too. We had to lay her down flat, since she became really pale and had a near syncope episode.  Called a EMS to the store. Gave her a few sips of coca cola. After the Emergency team arrival, they checked the patient for BP and BG. All were within range at the time and patient and mom refused to go to hospital (since patient had a similar episode after a prednisone shot). Afterwards the Emergency team escorted the mom and daughter to their car.
VACCINE GIVEN AFTER EXPIRATION DATE DUE TO TEMPERATURE CHANGE IN STORAGE; no adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (VACCINE GIVEN AFTER EXPIRATION DATE DUE TO TEMPERATURE CHANGE IN STORAGE) and NO ADVERSE EVENT (no adverse event) in a female patient of an unknown age who received mRNA-1273 (Spikevax) (batch no. 045L21A) for COVID-19 prophylaxis.     No Medical History information was reported.  On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (Intramuscular use) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (VACCINE GIVEN AFTER EXPIRATION DATE DUE TO TEMPERATURE CHANGE IN STORAGE) and NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (VACCINE GIVEN AFTER EXPIRATION DATE DUE TO TEMPERATURE CHANGE IN STORAGE) and NO ADVERSE EVENT (no adverse event) outcome was unknown.     For mRNA-1273 (Spikevax) (Intramuscular use), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (VACCINE GIVEN AFTER EXPIRATION DATE DUE TO TEMPERATURE CHANGE IN STORAGE).    Concomitant product use was not provided by the reporter.  It is unknown if the patient experienced any additional symptoms/events.   Treatment information was not provided.
This spontaneous report was received from a certified medical assistant (healthcare worker) refers to a patient of unknown age. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 13-JAN-2016, the patient was vaccinated with an improperly stored GARDASIL 9 lot # L016428, 30-JUL-2017. This is one of the several reports received from the same reporter. Additional information has been requested.
Dermatomal outbreak of possible herpes infection following second dose of Pfizer. Also viral xanthem rash reaction.
This case was reported by a consumer via call center representative and described the occurrence of suspected vaccination failure in a male patient who received SHINGRIX for prophylaxis. Co-suspect products included SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX and the 2nd dose of SHINGRIX. On an unknown date, unknown after receiving SHINGRIX and SHINGRIX, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to SHINGRIX and SHINGRIX. Additional details were provided as follows: This case was reported by the patient's brother. The age at vaccination was not reported. The patient received both the SHINGRIX shots and still experienced shingles. The reporter was not comfortable to give the patient information and did not give consent to be followed up. This case was considered as suspected vaccination failure as time to onset for the event for targeted disease was unknown.
No adverse event; Patient was administered with vaccine 2 days after expiration date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient was administered with vaccine 2 days after expiration date) and NO ADVERSE EVENT (No adverse event) in a 28-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 015B22A) for COVID-19 prophylaxis.     It was unknown whether patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine.     On 14-Feb-2023, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 14-Feb-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient was administered with vaccine 2 days after expiration date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient was administered with vaccine 2 days after expiration date) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient was administered with vaccine 2 days after expiration date).    No concomitant medications were provided. No treatment medication was provided.
no adverse effects; Patient administered with the bivalent vaccine; 12 years old administered with the bivalent booster dose; This spontaneous case was reported by a patient family member or friend and describes the occurrence of WRONG PRODUCT ADMINISTERED (Patient administered with the bivalent vaccine), PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (12 years old administered with the bivalent booster dose) and NO ADVERSE EVENT (no adverse effects) in a 12-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7146B) for COVID-19 prophylaxis.     Previously administered products included for Product used for unknown indication: Pfizer COVID-19 Vaccine (Dose 1, lot number FL0007) on 30-Dec-2021, Pfizer COVID-19 Vaccine (Dose 2 and lot number FJ6369) on 03-Feb-2022. Past adverse reactions to the above products included No adverse event with Pfizer COVID-19 Vaccine and Pfizer COVID-19 Vaccine.    On 30-Sep-2022, the patient received third dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 30-Sep-2022, the patient experienced WRONG PRODUCT ADMINISTERED (Patient administered with the bivalent vaccine) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (12 years old administered with the bivalent booster dose). On an unknown date, the patient experienced NO ADVERSE EVENT (no adverse effects). At the time of the report, WRONG PRODUCT ADMINISTERED (Patient administered with the bivalent vaccine), PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (12 years old administered with the bivalent booster dose) and NO ADVERSE EVENT (no adverse effects) outcome was unknown.       Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter. This case was linked to US-MODERNATX, INC.-MOD-2022-654913 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-654913:Same reporter.
15 minutes after im shot, patient experienced itchy feeling and then flushed face  patient was administered diphenhydramine 25mg orally and observed . No additional side effects occurred
Febrile convulsion at home on the evening of date shot given. Taken to ER by ambulance-no focal injection found.
About 12 weeks pregnant   Headache  Fever Extreme fatigue  Chills Body aches
Gradually worsening tinnitus (ears ringing) that began the day after and continues to get worse.
significant soreness in and around injection site, headaches, stomach cramps, mild fever, malaise
This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu-like symptoms), SWELLING FACE (face swollen) and FATIGUE (fatigue) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. Concurrent medical conditions included Allergic reaction to antibiotics (Augmentin), Asthma and Irritable bowel syndrome. Concomitant products included TIMOLOL, VITAMIN D [VITAMIN D NOS] and VITAMIN B [VITAMIN B NOS] for an unknown indication. On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu-like symptoms) and FATIGUE (fatigue). On 30-Jan-2021, the patient experienced SWELLING FACE (face swollen). At the time of the report, INFLUENZA LIKE ILLNESS (flu-like symptoms), SWELLING FACE (face swollen) and FATIGUE (fatigue) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment for the events included Allegra and Benadryl for the swelling of the face. This case was linked to US-MODERNATX, INC.-MOD-2021-075052 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 19-May-2021: Patient race, ethnicity, height, weight, allergy, medical history added.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-075052:Second dose vaccination.
Patient felt light headed after the vaccine was given. She then became unresponsive in the chair for about 15 seconds. During this time she was twitching. When she came to she was still light headed.
Patient experienced lightheadedness and syncope starting about 5 minutes after vaccine. After lying down for 20 minutes and drinking some soda patient stated feeling back to normal.
Fever, chills, body aches, delusions, anorexia, behavior changes started appx 24 hours after vaccine - lasted 12 hours.
Fever started on 10/15/2011. Pneumonia was diagnosed on 10/21/2011.